Jenburkt Pharmaceuticals.Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jenburkt Pharmaceuticals.Ltd with three other
companies in this sector in India:
Medicamen Biotech Limited
sales of 1.23 billion Indian Rupees [US$17.07 million]
of which 100%
was Pharmaceuticals Formulations),
(1.24 billion Indian Rupees [US$17.23 million]
of which 49%
was API), and
ANG Lifesciences India Ltd
(1.22 billion Indian Rupees [US$16.94 million]
Jenburkt Pharmaceuticals.Ltd reported sales of 1.23 billion Indian Rupees (US$17.07 million)
March of 2019.
increase of 7.0%
versus 2018, when the company's sales were 1.15 billion Indian Rupees.
Sales at Jenburkt Pharmaceuticals.Ltd have increased during each of the previous five years
(and since 2014, sales have increased a total of 61%).